--- title: "Tango Therapeutics (TNGX.US) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/TNGX.US/norm.md" symbol: "TNGX.US" name: "Tango Therapeutics" parent: "https://longbridge.com/zh-CN/quote/TNGX.US.md" datetime: "2026-05-21T08:00:29.693Z" locales: - [en](https://longbridge.com/en/quote/TNGX.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/TNGX.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/TNGX.US/norm.md) --- # Tango Therapeutics (TNGX.US) — 财务报表 ## 利润表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 每股收益 | -0.3170 | -0.2945 | 0.1300 | -0.3515 | -0.3615 | | ROE | -49.36% | -61.24% | 43.08% | -103.02% | -87.10% | | 营业收入 | - | 0.0000 | 53.81M | 3.18M | 5.39M | | 净利润 | -45.51M | -38.75M | 15.88M | -38.85M | -39.88M | | 营业利润 | -48.77M | -41.86M | 14.07M | -40.97M | -42.53M | | 毛利率 | - | - | 42.73% | -931.34% | -575.85% | | 净利率 | - | - | 29.52% | -1221.41% | -739.54% | | 利润含金量 | - | - | -45.46% | - | - | ## 资产负债表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 资产与负债 | 435.79M | 398.69M | 210.14M | 237.89M | 274.31M | | 权益乘数 | 1.11 | 1.15 | 1.31 | 1.76 | 1.65 | | 每股净资产 | 2.72 | 2.55 | 1.43 | 1.22 | 1.54 | | 资产周转率 | 0.1605 | 0.1745 | 0.2364 | 0.0785 | 0.1205 | | 现金及短投 | 379.84M | 343.14M | 152.81M | 180.78M | 216.72M | | 存货与应收 | - | - | - | - | - | | 长期投资 | 41.03M | 42.49M | 43.93M | 45.34M | 47.24M | | 净债务 | -347.05M | -309.57M | -118.05M | -145.78M | -179.78M | ## 现金流量表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 经营现金流 | -44.36M | -29.72M | -30.95M | -36.52M | -41.70M | | 投资现金流 | 9.63M | -135.72M | 47.48M | 16.78M | 30.60M | | 融资现金流 | 79.85M | 219.38M | 2.54M | 581000.00 | 2000.00 | | 自由现金流 | -28.53M | -15.98M | -7.98M | -15.74M | -21.16M | | 现金流充裕率 | - | -13386.49% | -20498.01% | -5852.40% | -81758.82% | | 举债与偿债 | - | - | - | - | - | | 资本支出 | - | -222000.00 | -151000.00 | -624000.00 | -51000.00 |